[go: up one dir, main page]

EE200200610A - Trombopoetiiniretseptorit moduleeriv peptiid - Google Patents

Trombopoetiiniretseptorit moduleeriv peptiid

Info

Publication number
EE200200610A
EE200200610A EEP200200610A EEP200200610A EE200200610A EE 200200610 A EE200200610 A EE 200200610A EE P200200610 A EEP200200610 A EE P200200610A EE P200200610 A EEP200200610 A EE P200200610A EE 200200610 A EE200200610 A EE 200200610A
Authority
EE
Estonia
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
EEP200200610A
Other languages
English (en)
Inventor
Naranda Tatjana
Olsson Lennart
Original Assignee
PLIVA, farmaceutska industrija, dionicko dru�tvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLIVA, farmaceutska industrija, dionicko dru�tvo filed Critical PLIVA, farmaceutska industrija, dionicko dru�tvo
Publication of EE200200610A publication Critical patent/EE200200610A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200200610A 2000-04-25 2001-04-23 Trombopoetiiniretseptorit moduleeriv peptiid EE200200610A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
EE200200610A true EE200200610A (et) 2004-08-16

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200610A EE200200610A (et) 2000-04-25 2001-04-23 Trombopoetiiniretseptorit moduleeriv peptiid

Country Status (24)

Country Link
US (1) US20030181659A1 (et)
EP (2) EP1149906A1 (et)
JP (1) JP2003530867A (et)
KR (1) KR20030009450A (et)
CN (1) CN1426467A (et)
AR (1) AR030278A1 (et)
AU (2) AU2001267366B9 (et)
BG (1) BG107214A (et)
BR (1) BR0110383A (et)
CA (1) CA2407167A1 (et)
CZ (1) CZ20023517A3 (et)
EA (1) EA006423B1 (et)
EE (1) EE200200610A (et)
GE (1) GEP20063763B (et)
HU (1) HUP0300559A3 (et)
IL (1) IL152204A0 (et)
IS (1) IS6582A (et)
MX (1) MXPA02010458A (et)
NO (1) NO20025114L (et)
PL (1) PL358304A1 (et)
SK (1) SK15262002A3 (et)
WO (1) WO2001080873A2 (et)
YU (1) YU79202A (et)
ZA (1) ZA200208662B (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039476A2 (en) * 2001-11-07 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
CA2499625A1 (en) * 2002-09-18 2004-04-01 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
PL377477A1 (pl) 2002-12-11 2006-02-06 Ferrosan A/S Materiały na bazie żelatyny jako waciki
CN1849141A (zh) * 2003-05-12 2006-10-18 阿费麦克斯公司 用于聚(乙二醇)修饰的肽的间隔臂部分
DE602004028725D1 (de) * 2003-05-12 2010-09-30 Affymax Inc Neue poly(ethylenglycol) modifizierte erythropoietinagonisten und deren verwendungen
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
US7923031B2 (en) 2004-01-30 2011-04-12 Ferrosan Medical Devices A/S Haemostatic sprays and compositions
CN101001649B (zh) 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
US20090004673A1 (en) * 2006-01-31 2009-01-01 Mitsubishi Kagaku Iatron, Inc. Method for Determining Condition of Disseminated Intravascular Coagulation
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
SG195007A1 (en) * 2011-05-13 2013-12-30 Univ Tokyo Polynucleated megakaryocytic cell and method for manufacturing platelets
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
WO2017005590A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
YU34196A (sh) * 1995-06-07 1999-03-04 Glaxo Group Limited Peptidi i jedinjenja koja se vezuju za receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
EP1064015A2 (en) * 1998-02-24 2001-01-03 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
AU2001267366B2 (en) 2005-06-30
HUP0300559A3 (en) 2005-09-28
SK15262002A3 (sk) 2003-05-02
GEP20063763B (en) 2006-03-10
WO2001080873A3 (en) 2002-01-31
BG107214A (bg) 2003-11-28
IS6582A (is) 2002-10-14
WO2001080873A2 (en) 2001-11-01
IL152204A0 (en) 2003-05-29
EA006423B1 (ru) 2005-12-29
EP1278849A2 (en) 2003-01-29
MXPA02010458A (es) 2003-06-06
JP2003530867A (ja) 2003-10-21
NO20025114L (no) 2002-12-18
CN1426467A (zh) 2003-06-25
PL358304A1 (en) 2004-08-09
CA2407167A1 (en) 2001-11-01
KR20030009450A (ko) 2003-01-29
NO20025114D0 (no) 2002-10-24
AR030278A1 (es) 2003-08-20
YU79202A (sh) 2006-01-16
AU2001267366B9 (en) 2005-07-14
CZ20023517A3 (cs) 2003-10-15
EA200201138A1 (ru) 2003-06-26
AU6736601A (en) 2001-11-07
EP1149906A1 (en) 2001-10-31
HUP0300559A2 (hu) 2003-06-28
ZA200208662B (en) 2003-10-27
US20030181659A1 (en) 2003-09-25
BR0110383A (pt) 2003-01-21

Similar Documents

Publication Publication Date Title
EE200200610A (et) Trombopoetiiniretseptorit moduleeriv peptiid
DE60113887D1 (de) Projektor
DE60133295D1 (de) Sulphoniumsalz-verbindung
FI20002644A0 (fi) Liitäntäalusta
NO20030917D0 (no) Anvendelse
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
EP1288221A4 (en) oligopeptides
NO20024322L (no) Sekvens
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
DE60138276D1 (de) Projektor
DE60112167D1 (de) Vibrator
DE60132814D1 (de) Te
ATA4432000A (de) Streugerät
NO20025533D0 (no) Sulfonamidderivater
NO20032963D0 (no) Peptidforbindelser
DE50106006D1 (de) Streugerät
NO20025459D0 (no) Sulfonamidderivater
EP1246834A4 (en) EPIDIDYMAL ANTIMICROBIAL PEPTIDES
NO20032221D0 (no) Vibrasjonsseparator
DE50113877D1 (de) Sägezahngarnitur
FI20002120A0 (fi) Sammutin
NO20024677D0 (no) Rist
SK2741U (sk) Viazacia pomôcka
SE0001833D0 (sv) Peptidkonjugat